Year |
Citation |
Score |
2021 |
Verathamjamras C, Sriwitool TE, Netsirisawan P, Chaiyawat P, Chokchaichamnankit D, Prasongsook N, Srisomsap C, Svasti J, Champattanachai V. Aberrant RL2 O-GlcNAc antibody reactivity against serum-IgA1 of patients with colorectal cancer. Glycoconjugate Journal. 38: 55-65. PMID 33608772 DOI: 10.1007/s10719-021-09978-8 |
0.398 |
|
2020 |
Netsirisawan P, Chokchaichamnankit D, Saharat K, Srisomsap C, Svasti J, Champattanachai V. Quantitative proteomic analysis of the association between decreasing O‑GlcNAcylation and metastasis in MCF‑7 breast cancer cells. International Journal of Oncology. PMID 32236627 DOI: 10.3892/Ijo.2020.5022 |
0.319 |
|
2019 |
Weeraphan C, Phongdara A, Chaiyawat P, Diskul-Na-Ayudthaya P, Chokchaichamnankit D, Verathamjamras C, Netsirisawan P, Yingchutrakul Y, Roytrakul S, Champattanachai V, Svasti J, Srisomsap C. Phosphoproteome profiling of isogenic cancer cell-derived exosome reveals HSP90 as a potential marker for human cholangiocarcinoma. Proteomics. e1800159. PMID 31054213 DOI: 10.1002/Pmic.201800159 |
0.324 |
|
2018 |
Netsirisawan P, Chaiyawat P, Chokchaichamnankit D, Lirdprapamongkol K, Srisomsap C, Svasti J, Champattanachai V. Decreasing O-GlcNAcylation affects the malignant transformation of MCF-7 cells via Hsp27 expression and its O-GlcNAc modification. Oncology Reports. 40: 2193-2205. PMID 30106436 DOI: 10.3892/Or.2018.6617 |
0.522 |
|
2017 |
Ngiwsara L, Rojnueangnit K, Wattanasirichaigoon D, Tim-Aroon T, Sawangareetrakul P, Champattanachai V, Ketudat-Cairns JR, Svasti J. Molecular analysis of the novel IDS allele in a Thai family with mucopolysaccharidosis type II: The c.928C>T (p.Gln310*) transcript is sensitive to nonsense-mediated mRNA decay. Experimental and Therapeutic Medicine. 13: 2989-2996. PMID 28588666 DOI: 10.3892/Etm.2017.4303 |
0.33 |
|
2016 |
Chaiyawat P, Weeraphan C, Netsirisawan P, Chokchaichamnankit D, Srisomsap C, Svasti J, Champattanachai V. Elevated O-GlcNAcylation of Extracellular Vesicle Proteins Derived from Metastatic Colorectal Cancer Cells. Cancer Genomics & Proteomics. 13: 387-398. PMID 27566657 |
0.404 |
|
2015 |
Sawangareetrakul P, Ketudat Cairns JR, Vatanavicharn N, Liammongkolkul S, Wasant P, Svasti J, Champattanachai V. Analysis of Novel Mutations and Methylmalonyl-CoA Mutase Levels in Thai Patients with Isolated Methylmalonic Acidemia. Biochemical Genetics. 53: 310-8. PMID 26370686 DOI: 10.1007/S10528-015-9694-9 |
0.309 |
|
2015 |
Chaiyawat P, Chokchaichamnankit D, Lirdprapamongkol K, Srisomsap C, Svasti J, Champattanachai V. Alteration of O-GlcNAcylation affects serine phosphorylation and regulates gene expression and activity of pyruvate kinase M2 in colorectal cancer cells. Oncology Reports. 34: 1933-42. PMID 26252736 DOI: 10.3892/Or.2015.4178 |
0.512 |
|
2015 |
Netsirisawan P, Chokchaichamnankit D, Srisomsap C, Svasti J, Champattanachai V. Proteomic Analysis Reveals Aberrant O-GlcNAcylation of Extracellular Proteins from Breast Cancer Cell Secretion. Cancer Genomics & Proteomics. 12: 201-9. PMID 26136220 |
0.389 |
|
2014 |
Chaiyawat P, Netsirisawan P, Svasti J, Champattanachai V. Aberrant O-GlcNAcylated Proteins: New Perspectives in Breast and Colorectal Cancer. Frontiers in Endocrinology. 5: 193. PMID 25426101 DOI: 10.3389/Fendo.2014.00193 |
0.459 |
|
2013 |
Phueaouan T, Chaiyawat P, Netsirisawan P, Chokchaichamnankit D, Punyarit P, Srisomsap C, Svasti J, Champattanachai V. Aberrant O-GlcNAc-modified proteins expressed in primary colorectal cancer. Oncology Reports. 30: 2929-36. PMID 24126823 DOI: 10.3892/Or.2013.2794 |
0.501 |
|
2013 |
Champattanachai V, Netsirisawan P, Chaiyawat P, Phueaouan T, Charoenwattanasatien R, Chokchaichamnankit D, Punyarit P, Srisomsap C, Svasti J. Proteomic analysis and abrogated expression of O-GlcNAcylated proteins associated with primary breast cancer. Proteomics. 13: 2088-99. PMID 23576270 DOI: 10.1002/Pmic.201200126 |
0.521 |
|
2012 |
Charoenwattanasatien R, Cairns JR, Keeratichamroen S, Sawangareetrakul P, Tanpaiboon P, Wattanasirichaigoon D, Pangkanon S, Svasti J, Champattanachai V. Decreasing activity and altered protein processing of human iduronate-2-sulfatase mutations demonstrated by expression in COS7 cells. Biochemical Genetics. 50: 990-7. PMID 22990955 DOI: 10.1007/S10528-012-9538-9 |
0.309 |
|
2009 |
Zou L, Yang S, Champattanachai V, Hu S, Chaudry IH, Marchase RB, Chatham JC. Glucosamine improves cardiac function following trauma-hemorrhage by increased protein O-GlcNAcylation and attenuation of NF-{kappa}B signaling. American Journal of Physiology. Heart and Circulatory Physiology. 296: H515-23. PMID 19098112 DOI: 10.1152/Ajpheart.01025.2008 |
0.617 |
|
2008 |
Champattanachai V, Marchase RB, Chatham JC. Glucosamine protects neonatal cardiomyocytes from ischemia-reperfusion injury via increased protein O-GlcNAc and increased mitochondrial Bcl-2. American Journal of Physiology. Cell Physiology. 294: C1509-20. PMID 18367586 DOI: 10.1152/Ajpcell.00456.2007 |
0.641 |
|
2007 |
Champattanachai V, Marchase RB, Chatham JC. Glucosamine protects neonatal cardiomyocytes from ischemia-reperfusion injury via increased protein-associated O-GlcNAc. American Journal of Physiology. Cell Physiology. 292: C178-87. PMID 16899550 DOI: 10.1152/Ajpcell.00162.2006 |
0.65 |
|
2006 |
Nagy T, Champattanachai V, Marchase RB, Chatham JC. Glucosamine inhibits angiotensin II-induced cytoplasmic Ca2+ elevation in neonatal cardiomyocytes via protein-associated O-linked N-acetylglucosamine. American Journal of Physiology. Cell Physiology. 290: C57-65. PMID 16107505 DOI: 10.1152/Ajpcell.00263.2005 |
0.609 |
|
Show low-probability matches. |